On August 5th 2020, just 4 years after the FDA’s deeming regulations on the the cigar industry took effect, the U.S. Food and Drug Administration submitted a court filing which essentially proposed a program that will allow manufacturers to request a deferral on submitting substantial equivalence reports. Essentially it allows premium cigar manufacturers to apply Read more about Cigar News: FDA Acknowledges their Huge Workload for Substantial Equivalence Reports and Offers Possible Deferment[…]